Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

about

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

Item

http://www.wikidata.org/entity/Q46159940

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@en

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@nl

type

Item

label

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@en

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@nl

prefLabel

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@en

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@nl

P1476

Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.

@en

P2093

Anne Goodling

http://www.w3.org/2001/XMLSchema#string

Daniel Batlle

http://www.w3.org/2001/XMLSchema#string

Jan Wysocki

http://www.w3.org/2001/XMLSchema#string

John Ruzinski

http://www.w3.org/2001/XMLSchema#string

Kathryn Whitlock

http://www.w3.org/2001/XMLSchema#string

Mar Burgaya

http://www.w3.org/2001/XMLSchema#string

Maryam Afkarian

http://www.w3.org/2001/XMLSchema#string

P2860

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

A new equation to estimate glomerular filtration rate

Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium

New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases

Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells

Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

P304

F487-F494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00074.2017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

313

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28468961

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

5582909

http://www.w3.org/2001/XMLSchema#string